Europe faces substantial challenges in continuing to deliver high-quality healthcare services to its citizens. With growing populations, rigid financing models and rising health inequalities, the conventional, reactive 'sick care' model needs to move to a more proactive, preventative and participatory model of care.

Without this transition, by 2040, European healthcare services will face being overwhelmed and unaffordable with diminished access, adversely affecting citizens' health and productivity.

Listen to episode 28 of the Life Sciences Connect Podcast to hear our guests dive into the most crucial questions from The Future of Health in Europe report.

In episode 27 of the Life Sciences Connect Podcast, we speak to the authors of the Time to Change report and discuss the current state of the UK healthcare workforce, touching on topics including pay, diversity, work-life balance, and training. 

During our conversation, we explore the unrelenting challenges facing the UK’s healthcare workforce and share actionable, evidence-based solutions to help improve staff wellbeing, recruitment, and retention at a local level.

In Episode 26, our panel of industry experts dive into the key trends and challenges facing the consumer health industry. This is one not to miss.

With increased access to information, greater levels of choice and improved functionality of products and technology, consumers are increasingly taking a more proactive role in managing their own health. Tune in for our expert panel’s views on the future of the industry.

Tune in to the latest episode of the Life Sciences Connect podcast, where you will find Sara Siegel’s fireside chat about all things Global Healthcare

Episode 25 welcomes the new Global Head of Health and previous guest, Sara Siegel who discusses with Karen the various challenges impacting global healthcare systems today, their hopes and ambitions for the future.

Karen and the team explore the findings from the Future of Diagnostic Series  

Episode 24 podcast explores some of the themes highlighted in our two reports on the future of diagnostics and specifically how the adoption of innovation and new models of service delivery are transforming diagnostic imaging. 

Listen to episode twenty-three to hear Karen, and our guests dissect the findings from the latest annual R&D ROI Report which launched last month. This report has provided insights into the state of biopharma R&D since 2010. We have expanded the analysis over time and our data set now covers the top 20 pharma companies by R&D spend

In episode twenty-two, we explore the challenges facing UK government and public services. Tune in as our experts discuss the issues currently facing health and social care, from unsustainable levels of funding to longstanding pressures on the workforce.

Join Karen Taylor, Ed Roddis and Emma Horrell as they dissect the findings from the latest State of the State report to bring you a view of the state from the people who use and the people who run it: State of the State

On this episode of Life Sciences Connect podcast, we bring the discussion of emission reduction to the forefront. Hear our guest discuss further:

James Gregson – UK’s Life Sciences & Healthcare industry leader

At the start of October we launched our report: Embedding environmental sustainability into pharma’s DNA. In this episode of we explore the pressing challenges facing pharma in achieving ambitious environmental sustainability targets and evaluate ways of making progress through easy wins across the value chain, culture changes and new investment.

These quick wins can provide the license to make transformative, fundamental changes that are necessary to achieve pharma’s targets.

Listen to hear more on this topic.

On this episode of Life Sciences Connect podcast, we discuss these issues further with our panel of experts:

• Andy Flockhart, UK MedTech Leader
• Guido Baechler, CEO of Mainz Biomed

And of course, our host, Karen Taylor, Research Director, Centre for Health Solutions, Deloitte

Diagnostics play a pivotal role across the entire healthcare continuum from screening, detection and prognosis to patient stratification and condition monitoring

While diagnostics have always been one of the foundations of healthcare, advances in science and technology mean they are now well positioned to play a key role in revolutionising healthcare. Driving the need for innovation are growing and ageing populations, the increasing prevalence of non-communicable diseases and chronic conditions, workforce shortages and an increasingly knowledgeable and empowered consumer base

Listen to hear more on this topic.

Episode 19 of the Life Sciences Connect podcast sheds light on the important topic of Health equity and dives into discussions around what this really means, what businesses can do to improve this, how diversity groups are affected and much more. To learn more about health equity and other important issues facing public health in the UK, explore out Future of Public Health Series